KPV

α-MSH Tripeptide Fragment

Strength: 5 mg · 10 mg

Pack Size: Single vial · 5-vial pack · 10-vial kit

Product specifications and published batch reports are available to browse. Verify your email, complete your research profile, and sign the laboratory-use attestation to access pricing and protected researcher features.

Verify researcher access →

Certificate of Analysis

Vanguard laboratory testing

10mg · Batch B004 · Original Vanguard Laboratory report. Reported/released November 3, 2026.

HPLC purity >99.80% HPLC-UV/VIS · V261015-9 001 Identity Pass - Matches Ref. Standard HPLC-UV/VIS · V261015-9 001 Measured quantity 9.92 mg HPLC-UV/VIS · V261015-9 001 Endotoxins <10.0 EU/vial LAL · V261015-9 001 Sterility No Growth Detected USP <71> · V261015-9 001 Heavy metals As/Cd/Pb/Hg: ND ICP-MS; As/Cd/Pb LOQ 0.01 ppm; Hg LOQ 0.005 ppm · V261015-9 001

Brief Description

KPV is supplied as a laboratory research material. Available quantities and batch-specific analytical documentation are listed on this page. For research use only; not for human or veterinary use.

Research Context

Immunomodulatory MechanismsResearch has characterized KPV's immunomodulatory effects independent of melanocortin receptor activation. Studies examine cytokine signaling modulation and immune cell pathway interactions in experimental models of immune response research.

Testing Archive

Review current and previous batch records, including COAs and supporting third-party testing documentation.

Browse Testing Archive →

Product Details

Form Lyophilized powder

Compound Specifications

CAS 67727-97-3

MW 342.43 g/mol

Formula C16H30N4O4

Storage & Handling

Consult the material’s current documentation and your laboratory’s approved procedures for receipt and storage.

For laboratory research use only — not for human consumption

Need a different size? Let us know →